Are you wondering what the influence of the coronavirus will be on your studies? Visit our corona FAQ for prospective students.
Drug Innovation: a unique programme
Drug Innovation is about:
- developing new drugs to combat drug-resistant microorganisms
- using gene or protein technologies to create therapies targeted at individual patients
- finding a way to imprint the immune system to increase tolerance
- exploring the relationship between gut microbes and brain disease
- learning how to use proteomics to study stem cell development
- reducing the side effects of treatment by finding new ways to deliver drugs directly onto the tumor
- updating and speeding up the drug regulatory process
The Master’s in Drug Innovation programme focuses on diagnostics and the improvement and management of small molecule and biomolecular drugs. Drug innovation covers many topics such as the development of new vaccines and the study of antibodies, gene therapeutics, and medical nutrition. Once developed, a new drug then needs to go through approval, which raises a whole new set of challenges, for example the establishment of new methods and criteria for evaluating the quality, efficacy, safety, and performance of the drug.
This broad, interdisciplinary programme is open to graduates from a wide range of disciplines such as chemistry, biology, pharmaceutical sciences, biomedical sciences, or medicine.
Many elective courses
Our programme offers a diverse suite of elective courses. This means you can concentrate on the topics of most interest to you. You will also take an internship with one of the research teams working on drug innovation at Utrecht University. This work may lead to publication in scientific journals within the field or new drug patents or protocols.
Graduates of this programme may go on to undertake research in drug innovation at universities, in the pharmaceutical or and biotechnology industry or to work in science or healthcare.
Drug innovation is an interdisciplinary field, which pulls together expertise from chemical, biological and medical sciences. This interdisciplinarity is central to the search for new solutions to currently incurable diseases. You will contribute to this field by undertaking two internships over a total of 15 months and submitting a writing assignment.
After graduation, you will have the skills needed to translate a drug-related problem into a relevant research question and will also be able to design and perform the research needed to solve this question. Finally, you will also be able to critically reflect on your own research and report on it, both verbally and in writing. These skills are highly transferable and will enable you to work independently within a competitive labour market.
- Degree: This Master's programme is officially registered under its name in the Central Register of Higher Education Study Programmes
- Title: MSc
- Master's degree in: Biosciences
- Programme: Drug Innovation
- Accredited by the NVAO
- Croho code:
- Language of instruction:
- Part- or full-time status:
- 2 years
- Credits: 60 credits equals one year full-time study load (European Credit Transfer System, ECTS)
- Start of studies:
- Application deadline:
- Dutch & EU/EER students: 1 April
- Non-EU/EEA students: 1 April
- Tuition fees:
- Graduate school:
- Life Sciences